Citadel Advisors’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,383
| Closed | -$2.93K | – | 7261 |
|
|
2024
Q4 | $2.93K | Buy |
24,383
+100
| +0.4% | +$12 | ﹤0.01% | 5785 |
|
|
2024
Q3 | $2.53K | Sell |
24,283
-300
| -1% | -$31 | ﹤0.01% | 5564 |
|
|
2024
Q2 | $2.73K | Buy |
+24,583
| New | +$2.73K | ﹤0.01% | 5636 |
|
|
2023
Q3 | – | Sell |
-21,981
| Closed | -$5.06K | – | 6654 |
|
|
2023
Q2 | $5.06K | Buy |
+21,981
| New | +$5.06K | ﹤0.01% | 5458 |
|